Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Fifty Years of Global Immunization at CDC, 1966-2015.

Mast EE, Cochi SL, Kew OM, Cairns KL, Bloland PB, Martin R.

Public Health Rep. 2017 Jan/Feb;132(1):18-26. doi: 10.1177/0033354916681490. Epub 2016 Dec 19. No abstract available.

2.

Serological markers for monitoring historical changes in malaria transmission intensity in a highly endemic region of Western Kenya, 1994-2009.

Wong J, Hamel MJ, Drakeley CJ, Kariuki S, Shi YP, Lal AA, Nahlen BL, Bloland PB, Lindblade KA, Were V, Otieno K, Otieno P, Odero C, Slutsker L, Vulule JM, Gimnig JE.

Malar J. 2014 Nov 22;13:451. doi: 10.1186/1475-2875-13-451.

3.

Malaria Control during Mass Population Movements and Natural Disasters.

Bloland PB, Williams HA; National Research Council (US) Committee on Population, Program on Forced Migration and Health at the Mailman School of Public Health, Columbia University.

Washington (DC): National Academies Press (US); 2002.

4.

Adverse drug events resulting from use of drugs with sulphonamide-containing anti-malarials and artemisinin-based ingredients: findings on incidence and household costs from three districts with routine demographic surveillance systems in rural Tanzania.

Njau JD, Kabanywanyi AM, Goodman CA, Macarthur JR, Kapella BK, Gimnig JE, Kahigwa E, Bloland PB, Abdulla SM, Kachur SP.

Malar J. 2013 Jul 11;12:236. doi: 10.1186/1475-2875-12-236.

5.

Routine delivery of artemisinin-based combination treatment at fixed health facilities reduces malaria prevalence in Tanzania: an observational study.

Khatib RA, Skarbinski J, Njau JD, Goodman CA, Elling BF, Kahigwa E, Roberts JM, MacArthur JR, Gutman JR, Kabanywanyi AM, Smith EE, Somi MF, Lyimo T, Mwita A, Genton B, Tanner M, Mills A, Mshinda H, Bloland PB, Abdulla SM, Kachur SP.

Malar J. 2012 Apr 30;11:140. doi: 10.1186/1475-2875-11-140.

6.

Drug dispensing practices during implementation of artemisinin-based combination therapy at health facilities in rural Tanzania, 2002-2005.

Thwing JI, Njau JD, Goodman C, Munkondya J, Kahigwa E, Bloland PB, Mkikima S, Mills A, Abdulla S, Kachur SP.

Trop Med Int Health. 2011 Mar;16(3):272-9. doi: 10.1111/j.1365-3156.2010.02724.x. Epub 2011 Jan 12.

7.

dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo.

Alker AP, Kazadi WM, Kutelemeni AK, Bloland PB, Tshefu AK, Meshnick SR.

Trop Med Int Health. 2008 Nov;13(11):1384-91. doi: 10.1111/j.1365-3156.2008.02150.x.

8.

Dispensary level pilot implementation of rapid diagnostic tests: an evaluation of RDT acceptance and usage by providers and patients--Tanzania, 2005.

Williams HA, Causer L, Metta E, Malila A, O'Reilly T, Abdulla S, Kachur SP, Bloland PB.

Malar J. 2008 Nov 19;7:239. doi: 10.1186/1475-2875-7-239.

9.

Malaria in pregnant women in an area with sustained high coverage of insecticide-treated bed nets.

Kabanywanyi AM, Macarthur JR, Stolk WA, Habbema JD, Mshinda H, Bloland PB, Abdulla S, Kachur SP.

Malar J. 2008 Jul 21;7:133. doi: 10.1186/1475-2875-7-133.

10.

The anatomy of a malaria disaster: drug policy choice and mortality in African children.

Hastings IM, Korenromp EL, Bloland PB.

Lancet Infect Dis. 2007 Nov;7(11):739-48. Epub 2007 Sep 19. Review.

PMID:
17884732
11.

HIV immunosuppression and antimalarial efficacy: sulfadoxine-pyrimethamine for the treatment of uncomplicated malaria in HIV-infected adults in Siaya, Kenya.

Shah SN, Smith EE, Obonyo CO, Kain KC, Bloland PB, Slutsker L, Hamel MJ.

J Infect Dis. 2006 Dec 1;194(11):1519-28. Epub 2006 Oct 27.

PMID:
17083036
12.

Epidemiologic study and containment of a nosocomial outbreak of severe acute respiratory syndrome in a medical center in Kaohsiung, Taiwan.

Liu JW, Lu SN, Chen SS, Yang KD, Lin MC, Wu CC, Bloland PB, Park SY, Wong W, Tsao KC, Lin TY, Chen CL.

Infect Control Hosp Epidemiol. 2006 May;27(5):466-72. Epub 2006 Apr 26.

PMID:
16671027
13.

Prevalence of malaria parasitemia among clients seeking treatment for fever or malaria at drug stores in rural Tanzania 2004.

Patrick Kachur S, Schulden J, Goodman CA, Kassala H, Elling BF, Khatib RA, Causer LM, Mkikima S, Abdulla S, Bloland PB.

Trop Med Int Health. 2006 Apr;11(4):441-51.

14.

Rapid malaria screening and targeted treatment of United States-bound Montagnard refugees from Cambodia in 2002.

Causer LM, Bishop HS, Sharp DJ, Flagg EW, Calderon JF, Keane V, Shah JJ, Macarthur JR, Maloney SA, Cetron MS, Bloland PB.

Am J Trop Med Hyg. 2005 Jun;72(6):688-93.

PMID:
15964951
15.

Adherence to antimalarial combination therapy with sulfadoxine-pyrimethamine and artesunate in rural Tanzania.

Kachur SP, Khatib RA, Kaizer E, Fox SS, Abdulla SM, Bloland PB.

Am J Trop Med Hyg. 2004 Dec;71(6):715-22.

PMID:
15642960
16.

Malaria surveillance--United States, 2002.

Shah S, Filler S, Causer LM, Rowe AK, Bloland PB, Barber AM, Roberts JM, Desai MR, Parise ME, Steketee RW.

MMWR Surveill Summ. 2004 Apr 30;53(1):21-34.

17.

Trends in antimalarial drug deployment in sub-Saharan Africa.

Bloland PB, Kachur SP, Williams HA.

J Exp Biol. 2003 Nov;206(Pt 21):3761-9. Review.

18.

Antibiotic resistance and serotype distribution of Streptococcus pneumoniae colonizing rural Malawian children.

Feikin DR, Davis M, Nwanyanwu OC, Kazembe PN, Barat LM, Wasas A, Bloland PB, Ziba C, Capper T, Huebner RE, Schwartz B, Klugman KP, Dowell SF.

Pediatr Infect Dis J. 2003 Jun;22(6):564-7.

PMID:
12828156
19.

A contrarian view of malaria therapy policy in Africa.

Bloland PB.

Am J Trop Med Hyg. 2003 Feb;68(2):125-6. No abstract available.

PMID:
12641398
20.

The contribution of social science research to malaria prevention and control.

Williams HA, Jones C, Alilio M, Zimicki S, Azevedo I, Nyamongo I, Sommerfeld J, Meek S, Diop S, Bloland PB, Greenwood B.

Bull World Health Organ. 2002;80(3):251-2. No abstract available.

21.

Effect of Plasmodium falciparum parasitemia density on hemoglobin concentrations among full-term, normal birth weight children in western Kenya, IV. The Asembo Bay Cohort Project.

McElroy PD, ter Kuile FO, Lal AA, Bloland PB, Hawley WA, Oloo AJ, Monto AS, Meshnick SR, Nahlen BL.

Am J Trop Med Hyg. 2000 Apr;62(4):504-12.

PMID:
11220768
22.

Combination therapy for malaria in Africa: hype or hope?

Bloland PB, Ettling M, Meek S.

Bull World Health Organ. 2000;78(12):1378-88. Epub 2003 Nov 17. Review.

23.

Increased carriage of trimethoprim/sulfamethoxazole-resistant Streptococcus pneumoniae in Malawian children after treatment for malaria with sulfadoxine/pyrimethamine.

Feikin DR, Dowell SF, Nwanyanwu OC, Klugman KP, Kazembe PN, Barat LM, Graf C, Bloland PB, Ziba C, Huebner RE, Schwartz B.

J Infect Dis. 2000 Apr;181(4):1501-5. Epub 2000 Apr 13.

PMID:
10762585
24.

Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. III. The Asemobo Bay Cohort Project.

McElroy PD, Lal AA, Hawley WA, Bloland PB, Kuile FO, Oloo AJ, Harlow SD, Lin X, Nahlen BL.

Am J Trop Med Hyg. 1999 Dec;61(6):932-40.

PMID:
10674673
25.

Making malaria-treatment policy in the face of drug resistance.

Bloland PB, Ettling M.

Ann Trop Med Parasitol. 1999 Jan;93(1):5-23. Review.

PMID:
10492667
26.

Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children.

Bloland PB, Boriga DA, Ruebush TK, McCormick JB, Roberts JM, Oloo AJ, Hawley W, Lal A, Nahlen B, Campbell CC.

Am J Trop Med Hyg. 1999 Apr;60(4):641-8.

PMID:
10348241
27.

Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission I. Description of study site, general methodology, and study population.

Bloland PB, Ruebush TK, McCormick JB, Ayisi J, Boriga DA, Oloo AJ, Beach R, Hawley W, Lal A, Nahlen B, Udhayakumar V, Campbell CC.

Am J Trop Med Hyg. 1999 Apr;60(4):635-40.

PMID:
10348240
28.

Malaria surveillance--United States, 1995.

Williams HA, Roberts J, Kachur SP, Barber AM, Barat LM, Bloland PB, Ruebush TK 2nd, Wolfe EB.

MMWR CDC Surveill Summ. 1999 Feb 26;48(1):1-23.

PMID:
10074931
29.

Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa.

Bloland PB, Kazembe PN, Oloo AJ, Himonga B, Barat LM, Ruebush TK.

Trop Med Int Health. 1998 Jul;3(7):543-52.

30.

A systematic approach to the development of a rational malaria treatment policy in Zambia.

Barat LM, Himonga B, Nkunika S, Ettling M, Ruebush TK, Kapelwa W, Bloland PB.

Trop Med Int Health. 1998 Jul;3(7):535-42. Erratum in: Trop Med Int Health 1998 Oct;3(10):854.

31.

Prevalence of malaria parasitemia and accuracy of microscopic diagnosis in Haiti, October 1995.

Kachur SP, Nicolas E, Jean-Fran├žois V, Benitez A, Bloland PB, Saint Jean Y, Mount DL, Ruebush TK 2nd, Nguyen-Dinh P.

Rev Panam Salud Publica. 1998 Jan;3(1):35-9.

PMID:
9503961
32.
33.

Drug resistance among malaria and other parasites.

Barat LM, Bloland PB.

Infect Dis Clin North Am. 1997 Dec;11(4):969-87. Review.

PMID:
9421710
34.

Malarone-donation programme in Africa.

Bloland PB, Kazembe PN, Watkins WM, Doumbo OK, Nwanyanwu OC, Ruebush TK 2nd.

Lancet. 1997 Nov 29;350(9091):1624-5.

PMID:
9393355
35.

Amodiaquine.

Bloland PB, Ruebush TK.

Lancet. 1996 Dec 14;348(9042):1659-60. No abstract available.

PMID:
8962005
36.

Identification of T-cell determinants in natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in an adult population exposed to malaria.

Lal AA, Hughes MA, Oliveira DA, Nelson C, Bloland PB, Oloo AJ, Hawley WE, Hightower AW, Nahlen BL, Udhayakumar V.

Infect Immun. 1996 Mar;64(3):1054-9.

37.

Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1.

Steketee RW, Wirima JJ, Bloland PB, Chilima B, Mermin JH, Chitsulo L, Breman JG.

Am J Trop Med Hyg. 1996;55(1 Suppl):42-9.

PMID:
8702036
38.

Maternal HIV infection and infant mortality in Malawi: evidence for increased mortality due to placental malaria infection.

Bloland PB, Wirima JJ, Steketee RW, Chilima B, Hightower A, Breman JG.

AIDS. 1995 Jul;9(7):721-6.

PMID:
7546417
39.

Identification of T and B cell epitopes recognized by humans in the C-terminal 42-kDa domain of the Plasmodium falciparum merozoite surface protein (MSP)-1.

Udhayakumar V, Anyona D, Kariuki S, Shi YP, Bloland PB, Branch OH, Weiss W, Nahlen BL, Kaslow DC, Lal AA.

J Immunol. 1995 Jun 1;154(11):6022-30.

PMID:
7538540
40.

Brief report: malaria probably locally acquired in New Jersey.

Brook JH, Genese CA, Bloland PB, Zucker JR, Spitalny KC.

N Engl J Med. 1994 Jul 7;331(1):22-3. No abstract available.

41.

Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa.

Bloland PB, Lackritz EM, Kazembe PN, Were JB, Steketee R, Campbell CC.

J Infect Dis. 1993 Apr;167(4):932-7.

PMID:
8450258
42.

Usefulness of clinical case-definitions in guiding therapy for African children with malaria or pneumonia.

Redd SC, Bloland PB, Kazembe PN, Patrick E, Tembenu R, Campbell CC.

Lancet. 1992 Nov 7;340(8828):1140-3.

PMID:
1359219
43.

Co-trimoxazole for childhood febrile illness in malaria-endemic regions.

Bloland PB, Redd SC, Kazembe P, Tembenu R, Wirima JJ, Campbell CC.

Lancet. 1991 Mar 2;337(8740):518-20.

PMID:
1671892

Supplemental Content

Loading ...
Support Center